Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin.

Authors: András, Ibolya E; Eum, Sung Yong; Huang, Wen; Zhong, Yu; Hennig, Bernhard; Toborek, Michal

Published In Mol Cell Neurosci, (2010 Feb)

Abstract: HIV-1-infected brains are characterized by increased amyloid deposition. To study the influence of HIV-1 on amyloid beta (Abeta) homeostasis at the blood-brain barrier (BBB) level, we employed a model of brain microvascular endothelial cells exposed to HIV-1 in the presence or absence of Abeta. HIV-1 markedly increased endogenous Abeta levels and elevated accumulation of exogenous Abeta. Simvastatin, the HMG-CoA reductase inhibitor, blocked these effects. We next evaluated the effects of HIV-1 and/or simvastatin on expression of the receptor for lipoprotein related protein (LRP1) and the receptor for advanced glycation end products (RAGE), known to regulate Abeta transport across the BBB. LRP1 expression was not affected by HIV-1; however, it was increased by simvastatin. Importantly, simvastatin attenuated HIV-1-induced RAGE expression. These results suggest that HIV-1 may directly contribute to Abeta accumulation at the BBB level. In addition, statins may protect against increased Abeta levels associated with HIV-1 infection in the brain.

PubMed ID: 19944163 Exiting the NIEHS site

MeSH Terms: Amyloid beta-Peptides/metabolism*; Amyloid beta-Peptides/pharmacology; Brain/cytology; Cell Line, Transformed; Coculture Techniques/methods; Endothelial Cells*/drug effects; Endothelial Cells*/metabolism; Endothelial Cells*/virology; Gene Expression Regulation/drug effects; HIV-1/metabolism*; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*; Intercellular Signaling Peptides and Proteins/pharmacology; Low Density Lipoprotein Receptor-Related Protein-1/metabolism; Peptide Fragments/pharmacology; Receptor for Advanced Glycation End Products; Receptors, Immunologic/metabolism; Simvastatin/pharmacology*; Time Factors

Back
to Top